Vorhersage des Ergebnisses einer Person mit Akuter Myoloider Leukämie
Anmelder: Koninklijke Philips N.V. 🇳🇱
Details
- Veröffentlichungs-Nr.
- EP4722388
- Anmeldetag
- 3. Oktober 2024
- Veröffentlichung
- 8. April 2026
- Rechtsraum
- EP
- IPC
- C12Q1/6886(FANTL WENDY J et al.)(MILSTEIN CESAR et al.)(UNIV NEW YORK et al.)
Abstract
The invention relates to a method of predicting an outcome of a subject having AML, the method comprising determining or receiving the result of a determination of six or more gene expression levels selected from a gene signature, and, optionally, providing the prediction to a medical caregiver or the subject. The invention further describes an apparatus and a computer program product configured to prediction outcome of a subject having AML. In addition the invention described the use of a kit in prediction outcome of a subject having AML, and describes a therapy for use in the treatment of AML, the use comprising predicting an outcome of a subject having AML and providing a therapy adapted to the outcome.
Anmelder
- Firma
- Koninklijke Philips N.V.
- Land
- 🇳🇱 Niederlande
Niederländisches Technologieunternehmen mit Sitz in Amsterdam, spezialisiert auf Medizintechnik, Diagnosegeräte, Patientenüberwachung sowie Gesundheits- und Wellnessprodukte.
22.236 Patente in unserer Datenbank
Vertreten von
-
Philips Intellectual Property & Standards